XEL
64
6
MPC
44
3
WMT
63
3
KMB
30
2
TGNA
64
-2
CSX
65
3
LOW
56
3
CINF
48
3
VMC
65
2
BRK.B
40
2
URBN
62
2
PNC
67
3
LH
50
2
NTRS
57
-2
ROK
59
9
EXPE
96
5
PEG
60
5
CME
59
4
LRCX
52
2
AZO
52
-4
XEL
64
6
MPC
44
3
WMT
63
3
KMB
30
2
TGNA
64
-2
CSX
65
3
LOW
56
3
CINF
48
3
VMC
65
2
BRK.B
40
2
URBN
62
2
PNC
67
3
LH
50
2
NTRS
57
-2
ROK
59
9
EXPE
96
5
PEG
60
5
CME
59
4
LRCX
52
2
AZO
52
-4
Financhill
Back

Evaxion Biotech AS Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
6

EVAX
Evaxion Biotech AS

Last Price:
2.57
Seasonality Move:
-49.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Evaxion Biotech AS Price Quote

$2.57
+0.07 (+-1.91%)
(Updated: November 9, 2024 at 5:24 AM ET)

Evaxion Biotech AS Key Stats

Sell
6
Evaxion Biotech AS (EVAX) is a Sell
Day range:
$2.45 - $2.61
52-week range:
$2.26 - $13.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.46
P/B ratio:
188.45%
Volume:
25.6K
Avg. volume:
23.2K
1-year change:
-76.19%
Market cap:
$13.9M
Revenue:
$73K
EPS:
$-2.8

How Much Does Evaxion Biotech AS Make?

Is Evaxion Biotech AS Growing As A Company?

Data Unavailable

Evaxion Biotech AS Stock Price Performance

What Is Evaxion Biotech AS 52-Week High & Low?

Evaxion Biotech AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evaxion Biotech AS?

Is Evaxion Biotech AS Cash Flow Positive?

Data Unavailable

Evaxion Biotech AS Return On Invested Capital

  • Is Management Doing A Good Job?
    EVAX return on invested capital is -238.97%
  • What Is Evaxion Biotech AS Return On Assets?
    ROA measures how assets are converting to revenues and is -69.51%
  • What Is EVAX Return On Equity?
    ROE is a measure of profitability and is 0%

Evaxion Biotech AS Earnings Date & Stock Price

Evaxion Biotech AS Competitors

  • Who Are Evaxion Biotech AS's Competitors?
    Below is a list of companies who compete with Evaxion Biotech AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Akari Therapeutics PLC (AKTX)
    • Ascendis Pharma AS (ASND)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • Verona Pharma PLC (VRNA)

Evaxion Biotech AS Dividend Yield

Evaxion Biotech AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.56
Upside from Last Price: 362.5%

Major Shareholders

  • How many EVAX shares are owned by institutional investors?
    456.7K EVAX shares are owned by institutional investors
  • How many EVAX shares are owned by insiders?
    0 EVAX shares are owned by insiders